Europe backs continued use of Ariad Pharma's leukaemia drug
October 24, 2014 at 07:59 AM EDT
Oct 24 (Reuters) - European regulators recommended continued use of Ariad Pharmaceuticals Inc's cancer drug Iclusig in its already approved indications to treat certain kinds of leukaemia.
